1h Free Analyst Time
The polymeric biomaterials market is forecasted to grow by USD 8.10 bn during 2023-2028, accelerating at a CAGR of 10.01% during the forecast period. The report on the polymeric biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for medical and dental implants, rising number of hip and knee replacement surgeries, and increasing prevalence of dental diseases.
The polymeric biomaterials market is segmented as below:
By Type
- Natural polymers
- Synthetic polymers
- Degradable polymers
By Application
- Orthopedics
- Cardiovascular
- Dental
- Plastic surgery
- Neurology and others
By Geographical Landscape
- North America
- Europe
- APAC
- South America
- Middle East and Africa
The report on the polymeric biomaterials market covers the following areas:
- Polymeric biomaterials market sizing
- Polymeric biomaterials market forecast
- Polymeric biomaterials market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global polymeric biomaterials market: Anika Therapeutics Inc., Aspire Biotech Inc., BASF SE, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Corbion nv, Covestro AG, Danimer Scientific Inc., International Polymer Engineering, Koninklijke DSM NV, Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., RAG Stiftung, Regenity, REVA Medical LLC, RevBio Inc., Stryker Corp., Victrex Plc, and Zimmer Biomet Holdings Inc..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising use of polymeric biomaterials in tissue engineering.'
According to the report, one of the major drivers for this market is the rising demand for medical and dental implants.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Anika Therapeutics Inc.
- Aspire Biotech Inc.
- BASF SE
- Berkeley Advanced Biomaterials
- Bezwada Biomedical LLC
- Corbion nv
- Covestro AG
- Danimer Scientific Inc.
- International Polymer Engineering
- Koninklijke DSM NV
- Medtronic Plc
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corp.
- RAG Stiftung
- Regenity
- REVA Medical LLC
- RevBio Inc.
- Stryker Corp.
- Victrex Plc
- Zimmer Biomet Holdings Inc.
